Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Pozycja w akcjach #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Cena akcji
$0.000001
Ostatnia synchronizacja: 2023-12-13
Kapitalizacja rynkowa
$23.51
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Allena Pharmaceuticals, Inc. (ALNAQ)

Kategoria

Historia ceny akcji dla Allena Pharmaceuticals, Inc. (ALNAQ)
Najwyższa cena zamknięcia: $0.00 dnia 2023-12-01

Najniższa cena zamknięcia: $12.31 dnia 2017-11-01
Historia cen akcji firmy Allena Pharmaceuticals, Inc. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 -99.48%
2022 -98.68%
2021 -49.81%
2020 -41.78%
2019 -68.12%
2018 -43.00%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR